The confidential portions of this exhibit have been filed separately with the Securities and Exchange Commission pursuant to
a confidential treatment request in accordance with Rule 24b-2 of the Securities and Exchange Act of 1934, as amended.
REDACTED PORTIONS OF THIS EXHIBIT ARE MARKED BY AN ***.
SECOND AMENDMENT TO SALES REPRESENTATIVE SERVICES AGREEMENT
This Second Amendment to Sales Representative Services Agreement (the “Amendment”) is entered into as of this 10
day of May, 2010 by and between VENTIV COMMERCIAL SERVICES, LLC, a New Jersey limited liability company (“VCS”) and
ENDO PHARMACEUTICALS INC., A Delaware CORPORATION (“Client”). VCS and Client may each be referred to herein as a
“Party” and, collectively, as the “Parties.”
W I T N E S S E T H:
WHEREAS, VCS and Client are parties to a Sales Representative Services Agreement dated April 1, 2008 and an
Amendment to Sales Representative Services Agreement dated May 8, 2009 (collectively the “Agreement”) relating to the
provision by the VCS Field Force of certain sales and promotional services on behalf of Client.
WHEREAS, VCS and Client desire to amend the Agreement as set forth herein.
NOW THEREFORE, in consideration of the premises and other good and valuable consideration, the receipt and adequacy
of which is hereby acknowledged, it is agreed as follows:
1. Except as provided in this Amendment, the terms and conditions set forth in the Agreement shall remain unaffected by
execution of this Amendment. To the extent any provisions or terms set forth in this Amendment conflict with the terms set
forth in the Agreement, the terms set forth in this Amendment shall govern and control. Terms not otherwise defined herein,
shall have the meanings set forth in the Agreement.
2. Article II of the Agreement is amended to provide that the Term of the Agreement is hereby extended for an additional
two month period and the Term shall remain in effect through August 10, 2010. The period from June 11,